Alzheimer's, ADHD, Autism, Brain Injury Treatment, Mood Disorders New Jersey: The NeuroCognitive and Behavioral Institute » Neuro News

Neuro News



tDCS May Improve Post-Stroke Aphasia

Electrical Brain Stimulation May Improve Post-Stroke Aphasia Patients with long-term aphasia named more words with noninvasive technique by Judy George, Contributing Writer, MedPage Today, August 20, 2018 Transcranial direct current stimulation appeared helpful in stroke patients with
Read More

New Study Shows Teens And Screens Add Up To ADHD

Which Came First, ADHD or Screen Time? A new study shows that teens and screens add up to ADHD. Posted Jul 21, 2018 by Nina Shapiro M.D., Psychology Today “While many studies in recent years have shown that screens have a negative impact on social behaviors, sleep quality, and m
Read More

Transcranial Direct Current Stimulation Applications

By Liji Thomas, MD The use of transcranial direct current stimulation (tDCS) has been hampered by the lack of knowledge to its long-term adverse effects and by the potential misuse of the technology due to its very ease of its application. Despite the restrictions on the widespread us
Read More

Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults

Abstract Atrophy of the medial temporal lobe (MTL) occurs with aging, resulting in impaired episodic memory. Aerobic fitness is positively correlated with total hippocampal volume, a heavily studied memory-critical region within the MTL. However, research on associations between seden
Read More

Physically Fit Women Nearly 90 Percent Less Likely to Develop Dementia

MINNEAPOLIS – Women with high physical fitness at middle age were nearly 90 percent less likely to develop dementia decades later, compared to women who were moderately fit, according to a study published the March 14, 2018, online issue of Neurology®, the medical journal of the Ameri
Read More

Underutilization Of Brain Amyloid Scans Drives Cost And Hurts Alzheimer’s Disease Care

LONDON, July 16, 2017 /PRNewswire-USNewswire/ — Research reported at the Alzheimer’s Association International Conference (AAIC) 2017 in London highlighted the clinical value of amyloid-β PET scans, which detect the presence of amyloid-beta plaques in the brain – one
Read More

Phase II Clinical Trial for Treatment of Mild Alzheimer’s Disease

U.S. Study Participants Aged 60 to 85 with Mild Dementia Needed TEL AVIV, March 7, 2017 /PRNewswire/ – Neurim Pharmaceuticals Ltd. announced today that they are seeking up to 500 U.S. patients with mild Alzheimer’s Disease for the start of a Phase II Clinical trial of a ne
Read More

Alzheimer’s Association Releases 2017 Alzheimer’s Disease Facts and Figures

Alzheimer’s Association (http://www.alz.org) recently released its 2017 Alzheimer’s Disease Facts and Figures. The NeuroCognitive Institute is an active site of clinical trials for Alzheimer’s Disease. Clinical trials are the best way for researchers to find new ways to de
Read More

Neurim Pharmaceuticals announces first patients’ enrollments in ReCOGNITION

Neurim Pharmaceuticals announces first patients’ enrollments in ReCOGNITION – phase II clinical trial of Piromelatine for mild Alzheimer’s disease Tel Aviv, Israel, September 14, 2016 Neurim Pharmaceuticals (“Neurim”) announced today that the first patients hav
Read More

NCI’s medical director leads Caregiver Boot Camp

Image via Kendal.org  The medical director of the NeuroCognitive Institute, Dr. Gerald Tramontano, recently headed a Caregiver Boot Camp sponsored by the Kendal Charitable Funds. The program aims to offer support to family caregivers of people who might have dementia. Dr. Tramont
Read More

Call Now Button